Data sourcesSEC FORM 419m ago
HOUSE PTR19m ago
SEC 13F19m ago
ROBINHOOD CHAIN19m ago
Public company
SUPNSUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Disclosed transactions60
Buys / sells0 / 0
Max Insider Score12
Connections11with evidence
SUPN · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 100.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
|
8
HTHorich William ToddSVP, Commercial Operations |
SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition |
| Nov 4, 2026 traded Nov 2, 2026 |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,250 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,000 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 13.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 17.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 18.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | HTHorich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 13.5K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | SBSensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 24.2K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | SBSensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | SBSensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 8 | SBSensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 15.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 13.5K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 70.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 1,250 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,250 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | RJRubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 19.5K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 100.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,350 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,750 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 1,875 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,000 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 22.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 17.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 18.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 30.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | MFMottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 13.5K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 27.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 10.2K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 12.4K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 9,305 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,365 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,847 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,296 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | BCBarlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
| 12 | KAKhattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 205.0K sh | Nov 2, 2026 | Nov 4, 2026 traded Nov 2, 2026 | +2d | SEC FORM 4 | |
Director, President, CEO · Nov 4, 2026